Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer
Tomlins SA, Laxman B, Dhanasekaran SM et al. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature 2007; 448; 595-599.
Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer
Attard G, Clark J, Ambroisine L et al. Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer. Oncogene 2008; 27; 253-263.
TMPRSS2: ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort
Demichelis F, Fall K, Perner S et al. TMPRSS2: ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort. Oncogene 2007; 26; 4596-4599.
Chromosome 21 copy number but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocacrcinoma: a large case-control radical prostatectomy cohort analysis
Toubaji A, Albadine R, Meeker AK et al. Chromosome 21 copy number but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocacrcinoma: a large case-control radical prostatectomy cohort analysis. Modern Pathol. 2009; 22(Suppl. 1); 189A.
TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomy
Gopalan A, Leversha MA, Satagopan JM et al. TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomy. Cancer Res. 2009; 69; 1400-1406.
TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions
Cerveira N, Ribeiro FR, Peixoto A et al. TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions. Neoplasia 2006; 8; 826-832.